Literature DB >> 2992671

Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.

A Dray, L Nunan, W Wire.   

Abstract

The in vivo effects of a number of opioid agonists and antagonists were studied on the spontaneous reflex contractions of the urinary bladder recorded isometrically in the rat anesthetized with urethane. All substances were administered into the central nervous system by the intracereboventricular (i.c.v.) or spinal intrathecal (i.t.) route. The conformationally restricted enkephalin analogues [2-D-penicillamine, 5-L-cysteine] enkephalin (DPLCE), [2-D-penicillamine, 5-L-penicillamine] enkephalin (DPLPE) and [2-D-penicillamine, 5-D-penicillamine] enkephalin (DPDPE) produced dose-related inhibition of reflex bladder contractions when administered by the i.c.v. or i.t. route. Both the novel delta-opioid receptor antagonist ICI 154,129 (200-600 micrograms) [N,N-bisallyl-Tyr-Gly-Gly-Psi-(CH2S)-Phe-Leu-OH) and ICI 174,864 (1-3 micrograms) [N,N-dially-Tyr-Aib-Aib-Phe-Leu-OH: Aib = alpha-aminoisobutyric acid] attenuated or abolished the effects of DPLCE, DPLPE and DPDPE when administered by the i.c.v. or i.t. route. The antagonism observed was selective since the equipotent inhibition produced by the mu-opioid receptor agonist [D-Ala2, Me-Phe4, Gly(ol)5] enkephalin (DAGO) was unaffected. Overall, ICI 154,129 was considerably weaker than ICI 174,864 and both antagonists inhibited bladder activity at doses higher than those required to demonstrate delta-receptor antagonism. Further studies of the agonistic effect of ICI 174,864 showed that it was insensitive to low doses of naloxone (2 micrograms, i.c.v. or i.t.) but could be abolished by higher (10-15 micrograms) doses of naloxone. These observations suggested that the agonistic effect of ICI 174,864 was not mediated by mu-opioid receptor. beta-Endorphin (0.2-1.0 micrograms, i.c.v.) inhibited bladder contractions but following recovery from this effect, appeared to prevent the expression of delta-receptor antagonism by ICI 174,864. In addition a previously subthreshold dose of ICI 174,864 now exhibited marked agonistic activity. The inhibitory effect of a submaximal dose of DPDPE was also potentiated by beta-endorphin under these circumstances. These observations suggest that supra-spinal and spinal delta-opioid receptors are involved in the opioid-mediated inhibition of reflex bladder contractions in the rat. Moreover beta-endorphin may be important in regulating central delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992671      PMCID: PMC1916529          DOI: 10.1111/j.1476-5381.1985.tb10569.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  beta-Endorphin: characteristics of binding sites in the rat brain.

Authors:  P Ferrara; R Houghten; C H Li
Journal:  Biochem Biophys Res Commun       Date:  1979-08-13       Impact factor: 3.575

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse.

Authors:  H J Friedman; M F Jen; J K Chang; N M Lee; H H Loh
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

4.  Prediction of peptide retention times in high-pressure liquid chromatography on the basis of amino acid composition.

Authors:  J L Meek
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

5.  The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Life Sci       Date:  1980-07-14       Impact factor: 5.037

6.  A protein-lipid model of the opiate receptor.

Authors:  N M Lee; A P Smith
Journal:  Life Sci       Date:  1980-05-05       Impact factor: 5.037

7.  beta-Endorphin: characteristics of binding sites in rabbit spinal cord.

Authors:  P Ferrara; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Binding of 3H-beta-endorphin to rat brain membranes: characterization of opiate properties and interaction with ACTH.

Authors:  H Akil; W A Hewlett; J D Barchas; C H Li
Journal:  Eur J Pharmacol       Date:  1980-05-30       Impact factor: 4.432

9.  Selective delta-opioid receptor antagonism by ICI 174,864 in the central nervous system.

Authors:  A Dray; L Nunan
Journal:  Peptides       Date:  1984 Sep-Oct       Impact factor: 3.750

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  10 in total

Review 1.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Effects of morphine metabolites on micturition in normal, unanaesthetized rats.

Authors:  Y Igawa; D Westerling; A Mattiasson; K E Andersson
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin.

Authors:  Hitoshi Yokoyama; Katsumi Sasaki; Michael E Franks; William F Goins; James R Goss; William C de Groat; Joseph C Glorioso; Michael B Chancellor; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

Review 4.  Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Authors:  Naoki Yoshimura; Tomohiko Oguchi; Hitoshi Yokoyama; Yasuhito Funahashi; Satoru Yoshikawa; Yoshio Sugino; Naoki Kawamorita; Mahendra P Kashyap; Michael B Chancellor; Pradeep Tyagi; Teruyuki Ogawa
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

5.  Receptor binding studies of the flavone, REC 15/2053, and other bladder spasmolytics.

Authors:  G A Abbiati; R Ceserani; D Nardi; C Pietra; R Testa
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

6.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

7.  Actions of tramadol on micturition in awake, freely moving rats.

Authors:  Raj Kumar Pandita; Rikard Pehrson; Thomas Christoph; Elmar Friderichs; Karl-Erik Andersson
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

8.  Role of the endogenous opioid system in modulation of urinary bladder activity by spinal nerve stimulation.

Authors:  Xin Su; Angela Nickles; Dwight E Nelson
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-01

9.  Efficacy of Acupuncture in Children with Nocturnal Enuresis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zheng-Tao Lv; Wen Song; Jing Wu; Jun Yang; Tao Wang; Cai-Hua Wu; Fang Gao; Xiao-Cui Yuan; Ji-Hong Liu; Man Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-16       Impact factor: 2.629

Review 10.  Physical Agent-Based Treatments for Overactive Bladder: A Review.

Authors:  Nurida Khasanah; Hung-Yen Chin; Chih-Wei Peng
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.